Celltrion Q3 operating profit tops W500 bil. mark for 1st time

Biotech firm Celltrion announced on Monday that its operating profit for the third quarter of 2026 is projected to exceed the 500 billion won ($374.3 million) threshold for the first time, thanks to strong sales in international markets. The company issued its earnings guidance on Monday, projecting 1.5 trillion won in revenue and 510 billion won in operating profit for the three-month period, reflecting year-over-year increases of 45.8 percent and 69.2 percent, respectively.

Both revenue and profit hit new quarterly peaks, with operating profit surpassing the 500 billion won mark for the first time since Celltrion's inception. The company attributed its improved profitability to a higher proportion of high-margin products in its sales mix and enhancements in its cost structure. In January, Celltrion had set quarterly operating profit targets of over 300 billion won for Q1, 400 billion won for Q2, and 500 billion won for Q3.

The company revealed that it has surpassed its targets in each of the first three quarters, indicating that its profit growth is on track as planned.